Skip to search formSkip to main contentSkip to account menu

Cyclophosphamide

Known as: CPM, 2H-1,3,2-oxazaphosphorin-2-amine, N,N-is(2-chloroethyl)tetrahydro-,2-oxide, N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide 
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
The Microbiota Makes for Good Therapy The gut microbiota has been implicated in the development of some cancers, such as… 
Highly Cited
2010
Highly Cited
2010
BACKGROUND Cyclophosphamide and glucocorticoids have been the cornerstone of remission-induction therapy for severe… 
Highly Cited
2009
Highly Cited
2009
Recent studies have suggested that mycophenolate mofetil (MMF) may offer advantages over intravenous cyclophosphamide (IVC) for… 
Highly Cited
2007
Highly Cited
2007
Chlamydomonas reinhardtii is a unicellular green alga whose lineage diverged from land plants over 1 billion years ago. It is a… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND We conducted a double-blind, randomized, placebo-controlled trial to determine the effects of oral cyclophosphamide on… 
Highly Cited
2005
Highly Cited
2005
Abstract Objective To evaluate the safety of home births in North America involving direct entry midwives, in jurisdictions where… 
Highly Cited
1996
Highly Cited
1996
BACKGROUND Intravenous platinum-based chemotherapy is the standard primary therapy for advanced ovarian cancer. We conducted a… 
Highly Cited
1947
Highly Cited
1947
Background: Little is known about patients who frequently visit the emergency department (ED) for acute exacerbation of chronic…